Correlation Between Sarepta Therapeutics and Exelixis

Can any of the company-specific risk be diversified away by investing in both Sarepta Therapeutics and Exelixis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarepta Therapeutics and Exelixis into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sarepta Therapeutics and Exelixis, you can compare the effects of market volatilities on Sarepta Therapeutics and Exelixis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarepta Therapeutics with a short position of Exelixis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarepta Therapeutics and Exelixis.

Diversification Opportunities for Sarepta Therapeutics and Exelixis

-0.16

Correlation Coefficient

Sarepta Therapeutics  Exelixis

Good diversification

The 3 months correlation between Sarepta and Exelixis is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Sarepta Therapeutics and Exelixis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exelixis and Sarepta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarepta Therapeutics are associated (or correlated) with Exelixis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exelixis has no effect on the direction of Sarepta Therapeutics i.e., Sarepta Therapeutics and Exelixis go up and down completely randomly.

Pair Corralation between Sarepta Therapeutics and Exelixis

Given the investment horizon of 90 days Sarepta Therapeutics is expected to generate 138.03 times less return on investment than Exelixis. In addition to that, Sarepta Therapeutics is 1.15 times more volatile than Exelixis. It trades about 0.0 of its total potential returns per unit of risk. Exelixis is currently generating about 0.18 per unit of volatility. If you would invest  2,596  in Exelixis on September 27, 2024 and sell it today you would earn a total of  786.00  from holding Exelixis or generate 30.28% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Sarepta Therapeutics  vs.  Exelixis

Sarepta Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sarepta Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Sarepta Therapeutics is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Exelixis

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Exelixis are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical and fundamental indicators, Exelixis disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sarepta Therapeutics and Exelixis

The main advantage of trading using opposite Sarepta Therapeutics and Exelixis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarepta Therapeutics position performs unexpectedly, Exelixis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exelixis will offset losses from the drop in Exelixis' long position.

The idea behind Sarepta Therapeutics and Exelixis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.